chlorprothixene and Basal Ganglia Diseases

chlorprothixene has been researched along with Basal Ganglia Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aaskoven, O; Ravn, J; Scharff, A1
Dose, M; Emrich, HM; Hellweg, R; Theison, M; Yassouridis, A1
Gabriel, E; Karobath, M; Lenz, G1
Fowler, PJ; Kaiser, C; Macko, E; Sarau, H; Tedeschi, DH; Zirkle, CL1
Swett, C1

Trials

1 trial(s) available for chlorprothixene and Basal Ganglia Diseases

ArticleYear
Combined treatment of schizophrenic psychoses with haloperidol and valproate.
    Pharmacopsychiatry, 1998, Volume: 31, Issue:4

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Brief Psychiatric Rating Scale; Chlorprothixene; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Haloperidol; Humans; Leukopenia; Schizophrenia; Valproic Acid

1998

Other Studies

4 other study(ies) available for chlorprothixene and Basal Ganglia Diseases

ArticleYear
[20 years experience with chlorprothixene (author's transl)].
    Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1980, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Aged; Alcoholism; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Depression; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Middle Aged; Neurotic Disorders; Psychoses, Alcoholic; Schizophrenia

1980
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
    Der Nervenarzt, 1976, Volume: 47, Issue:1

    Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine

1976
Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Arzneimittel-Forschung, 1977, Volume: 27, Issue:4

    Topics: Acridines; Adenylyl Cyclase Inhibitors; Animals; Antipsychotic Agents; Apomorphine; Autonomic Nervous System; Basal Ganglia Diseases; Behavior, Animal; Chlorpromazine; Chlorprothixene; Conditioning, Psychological; Corpus Striatum; Dogs; Dopamine; Female; Haplorhini; Hemodynamics; Humans; Lethal Dose 50; Macaca mulatta; Male; Mice; Motor Activity; Rage; Rats; Reaction Time; Stereotyped Behavior; Trifluoperazine

1977
Drug-induced dystonia.
    The American journal of psychiatry, 1975, Volume: 132, Issue:5

    Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphenazine; Haloperidol; Humans; Male; Mental Disorders; Mesoridazine; Middle Aged; Perphenazine; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Thioridazine; Thiothixene; Trifluoperazine

1975